Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

OBJECTIVE: To evaluate the relationship between number of metabolic syndrome (MetS)-like components and prostate cancer diagnosis in a group of men where nearly all biopsies were taken independent of prostate-specific antigen (PSA) level, thus minimising any confounding from how the various MetS-lik...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BJU Int
Hlavní autoři: Sourbeer, Katharine N., Howard, Lauren E., Andriole, Gerald L., Moreira, Daniel M., Castro-Santamaria, Ramiro, Freedland, Stephen J., Vidal, Adriana C.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4564864/
https://ncbi.nlm.nih.gov/pubmed/24931061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.12843
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky